Four Boston area Israeli collaborations receive $1.3 in funding for innovative medical and energy projects under new MA/Israel partnership.
Author: Anita M. Harris
Picketers greet 15,000 participants at BIO 2012 Convention in Boston
Share this on : Facebook Friendfeed Posterous Tumblr Twitter
AC Immune/Genentech to Partner on R&D for Alzheimer’s Antibody; $418M Agree’t
AC Immune has entered into a second exclusive worldwide license agreement and research collaboration with Genentech,of the Roche Group, for the research, development and commercialization of AC Immune’s anti-Tau antibodies for the potential treatment of Alzheimer’s disease and other neurodegenerative diseases. The agreement is valued at $400M.
International & MA Cancer R&D Clusters Showcased at Whitehead Institute
Four Boston-area startups were showcased in an international program on collaborative cancer research & therapy clusters held today at the Whitehead Institute in Cambridge.
UK Life Science Consulting Firm Alacrita To Open US HQ in Cambridge, MA
UK-based Alacrita, a global life science consulting firm, will soon be opening US headquarters in Kendall Square, Cambridge, MA.
Pasteur Institute Spin-out Ariana Pharma Opens Cambridge Office; Analytics Tech to Streamline Clinical Trials
Anita Harris of New Cambridge Observer writes that Ariana Pharma opens Ariana Data Intelligence, Inc., in Cambridge. Ariana offers “KEM” non-statistical analysis technology to streamline and to cut financial risk of clinical trials.
Healthbox expands to Cambridge; $50K health tech startup competition deadline is June 24.
Healthbox has launched a competition in which up to 10 New England-based companies will be selected to receive $50,000 in seed funding, collaborative workspace, access to a mentor network and strategic guidance in three-month program to start in August. The application deadline is June 24.
Newsrooms Must Adopt “Innovation Culture” To Survive, Google Exec says
Cambridge writer Anita Harris reports on Google News Exec’s advice to newspaper industry at Nieman Foundation, May 11, 2012